Tendon injuries recur in more than half of horses managed conventionally. A new randomized controlled trial tested a two-step approach — PRP followed by autologous muscle-derived stem cells — and found meaningful clinical and ultrasonographic improvements in horses that hadn't responded to PRP alone.